Project Number 5R21NS099631-02 Agency/Funding Organization NINDS Funding Year 2018 View Full Project Details for C9ORF72 levels: implications for diagnosis, prognosis, and treatment of ALS and related disorders Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies c. C9ORF-72 and Progranulin Researcher and Organization Principal Investigator VAN BLITTERSWIJK, MARKA Principal Investigator First Name MARKA Principal Investigator Last Name VAN BLITTERSWIJK Awardee Organization MAYO CLINIC JACKSONVILLE Awardee State Florida Contact PI Country United States Project Detail Funding Opportunity Announcement PA-13-303: NIH Exploratory/Developmental Research Grant Program (Parent R21) FY Overall Cost $195,625 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GUBITZ, AMELIE
